*WHO HAS MISLED THE PUBLIC, LIED AND CONCEALED THE FINANCIAL STAKE OF GSK IN AN EBOLA EMERGENCY DECLARATION
*WHO SPOKESPERSON GREGORY HARTL DENIED ANY EBOLA VACCINE WAS AVAILABLE IN AN EMAIL IN APRIL
*YET IN MARCH GSK APPROACHED WHO WITH ITS EBOLA VACCINE CANDIDATE
*AS SOON AS WHO DECLARED EBOLA AN INTERNATIONAL EMERGENCY IN AUGUST, GSK WAS GIVEN THE GREEN LIGHT TO PRODUCE THE EBOLA VACCINE
*LUCRATIVE CONTRACT WHICH COULD INVOLVE 230,000 DOSES IN APRIL ALREADY
*RERUN OF SWINE FLU SCANDAL OF 2009 WHEN WHO CONCEALED CONFLICTS OF INTERESTS FROM PUBLIC IN SWINE FLU EMERGENCY DECLARATION
*SCIENTISTS WITH LINKS TO GSK AND BIG PHARMA ADVISED WHO TO DECLARE SWINE FLU AN EMERGENCY, GENERATING WINDFALL
In May 2013 GlaxoSmithKline (GSK) bought a Swiss vaccine-maker for $325m, called Okairos, which had a preclinical Ebola vaccine candidate.
In March 2014, GSK contacted the World Health Organisation (WHO) to let it know that it had an Ebola vaccine.
That means, as early as March, WHO knew that GSK had a financial stake in WHO declaring Ebola declaration of emergency of international concern because such a declaration would trigger lucrative vaccine contracts for GSK.